Navigation Links
DURECT Corporation Invites You to Join its Third Quarter 2013 Earnings Conference Call
Date:10/28/2013

CUPERTINO, Calif., Oct. 28, 2013 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) third quarter 2013 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Monday, November 4, 2013 at 4:30 pm Eastern Time (1:30 pm Pacific Time).

(Logo:  http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations."  If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR, ELADUR®, and TRANSDUR®-Sufentanil.  DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit www.durect.com.

NOTE: POSIDUR, SABER®, ORADUR®, TRANSDUR®, and ELADUR® are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the U.S. Food and Drug Administration or other health authorities.


'/>"/>
SOURCE DURECT Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
2. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
3. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
4. DURECT to Participate in Upcoming Healthcare Conferences
5. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
6. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
7. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
8. DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference Call
9. DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
10. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
11. DURECT Announces Changes to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.24 ... 2017 to stockholders of record as of the close of ... subject to approval of the Board of Directors and may ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
(Date:8/2/2017)... 2, 2017 CaryRx, a next-generation full-service pharmacy, has ... for patients in the Washington D.C. ... by providing delivery of medications through the convenience of its ... or delivered within one hour to any location in D.C. ... bring this invaluable service to Washington D.C. ...
Breaking Medicine Technology:
(Date:8/19/2017)... ... August 19, 2017 , ... ... of breastfeeding mothers. These illustrations show the diversity of the breastfeeding mothers, ... a wide range of sizes. These illustrations are also available on tote bags, ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners of America ... as an interventional pain management physician. He brings a wealth of pain management ... headaches, and significant experience in spinal cord stimulation for chronic pain. , Dr. ...
(Date:8/18/2017)... , ... August 18, 2017 , ... More than 20,000 ... Republic of Congo (DRC) thanks to an ambitious venture that conjoined the passions of ... the generous support of the Liberty community. These shoes will save lives from the ...
(Date:8/18/2017)... NY (PRWEB) , ... August 18, 2017 , ... ... of “Vision & Hearing” campaign, advocating for active, healthy lifestyles and highlighting the ... available for individuals with hearing impairments and shares the latest innovations in hearing ...
(Date:8/18/2017)... ... 18, 2017 , ... As an industry leader, Eppendorf is ... will present the line of epMotion automated liquid handling system. This automated liquid ... everyday pipetting tasks. , Ideal for scientists and lab technicians with no or ...
Breaking Medicine News(10 mins):